- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- October 2026
- 50 Pages
Global
From €2436EUR$2,650USD£2,076GBP
- Report
- September 2026
- 180 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 193 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- January 2026
- 180 Pages
Global
From €4137EUR$4,500USD£3,526GBP
- Report
- October 2026
- 50 Pages
Global
From €2436EUR$2,650USD£2,076GBP
- Report
- September 2026
- 181 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 186 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 185 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 192 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- April 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more